- Home
- KALV vs BLW Comparison
KALV vs BLW Comparison
Compare KALV & BLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- BLW
- Stock Information
- Founded
- KALV N/A
- BLW 2003
- Country
- KALV United States
- BLW United States
- Employees
- KALV N/A
- BLW N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- BLW Other Consumer Services
- Sector
- KALV Health Care
- BLW Consumer Discretionary
- Exchange
- KALV Nasdaq
- BLW Nasdaq
- Market Cap
- KALV 563.1M
- BLW 506.7M
- IPO Year
- KALV N/A
- BLW N/A
- Fundamental
- Price
- KALV $11.45
- BLW $13.95
- Analyst Decision
- KALV Strong Buy
- BLW
- Analyst Count
- KALV 8
- BLW 0
- Target Price
- KALV $24.83
- BLW N/A
- AVG Volume (30 Days)
- KALV 567.9K
- BLW 85.9K
- Earning Date
- KALV 03-12-2025
- BLW 01-01-0001
- Dividend Yield
- KALV N/A
- BLW 8.83%
- EPS Growth
- KALV N/A
- BLW N/A
- EPS
- KALV N/A
- BLW 1.81
- Revenue
- KALV N/A
- BLW N/A
- Revenue This Year
- KALV N/A
- BLW N/A
- Revenue Next Year
- KALV N/A
- BLW N/A
- P/E Ratio
- KALV N/A
- BLW $7.73
- Revenue Growth
- KALV N/A
- BLW N/A
- 52 Week Low
- KALV $7.30
- BLW $12.35
- 52 Week High
- KALV $15.50
- BLW $14.26
- Technical
- Relative Strength Index (RSI)
- KALV 47.44
- BLW 34.84
- Support Level
- KALV $11.83
- BLW $13.91
- Resistance Level
- KALV $12.50
- BLW $14.08
- Average True Range (ATR)
- KALV 0.58
- BLW 0.10
- MACD
- KALV -0.16
- BLW -0.01
- Stochastic Oscillator
- KALV 19.46
- BLW 11.35
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About BLW Blackrock Limited Duration Income Trust
Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.